SOFINNOVA VENTURE PARTNERS IX, L.P.

MENLO PARK, CA Venture Capital Fund How do I update this listing?

Sofinnova Venture Partners IX is based out of Menlo Park. Whalewisdom has at least 20 13D filings, 5 13G filings, and 7 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2014-07-10. The filing was for a pooled investment fund: venture capital fund The notice included securities offered of Pooled Investment Fund Interests

Create Email Alert

Contact Info

sofinnova venture partners ix, l.p.
3000 SAND HILL ROAD, 4-250
MENLO PARK CA    94025

Business Phone: 650-681-8420
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
NextCure Inc (NXTC) HEALTH CARE 2,671,856 150,505,648.48 1 13D 2019-11-15
Galera Therapeutics Inc (GRTX) HEALTH CARE 3,084,810 40,596,099.60 2 13D 2019-11-12
Merus BV (MRUS) HEALTH CARE 1,311,039 17,161,500.51 3 13D 2020-04-17
Iterum Therapeutics Plc (ITRM) HEALTH CARE 1,732,668 7,727,699.28 4 13D 2020-01-16
Entasis Therapeutics Holdings Inc (ETTX) HEALTH CARE 1,180,178 5,865,484.66 5 13D 2018-09-28
Unknown (unknown) 1,726,514 6 13D 2018-05-30

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2014-07-10 D POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Pooled Investment Fund Interests 500,000,000 0 500,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANAND MEHRA subscription required
    EXECUTIVE OFFICER
JAMES I. HEALY subscription required
    EXECUTIVE OFFICER
MICHAEL F. POWELL subscription required
    EXECUTIVE OFFICER
SRINIVAS AKKARAJU subscription required
    EXECUTIVE OFFICER

Elevate your investments